Symptom-Based Dosing for Neonatal Opioid Withdrawal: The OPTimize NOW Randomized Clinical Trial.  Devlin LA, Babineau DC, Merhar SL, DeMauro SB, Kraft WK, Lorch SA, Das A, McDonald SA, Rhodes E, Schmidt AF, Trochinski L, Crawford M, Sithisarn…

Closing the Harm Reduction Gap: EMPOWERing People Who Smoke.  Reese L, Murphy MA, Murray K.  Cureus. 2026 Jun 18;18(6):e111096. doi: 10.7759/cureus.111096. PMID: 42328264; PMCID: PMC13278388. https://pmc.ncbi.nlm.nih.gov/articles/PMC132…

Centering the voices of young people who use opioids and youth harm reduction practitioners: insights from an international Youth RISE cohort.  Juristia A, Azvian V, Arredondo C, Calzada R, Rivera AC, Wambui S, Etepesit WO, Goodyear T. …

Perspectives on harm reduction kit implementation in heterogeneous outpatient clinics.  Jawa R, Shang M, Markus A, Hamm M, Luiggi-Hernández J, Cameron FA, McMurtrie G, Studnicki O, Hawk M, Check D, Merlin J, Liebschutz J.  Subst Abuse Tr…

"People are going to do drugs:" harm reduction as a strategy for survivors of sex trafficking who use substances.  Gezinski LB, Richer AMS, Dilanchian A, Anasti T, Dell NA, Price C.  Harm Reduct J. 2026 Jun 29. doi: 10.1186/s12954-026-01…

Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013-2023.  Kan M, Holmén E, Brynte C, Ekström AM, Kåberg M.  Int J Drug Policy. 2026 Jul;153…